CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma

202243 citationslettergold Open Access

Authors

Feng Wang · Sichuan University

Fen Zhao · Sichuan University

Li Zhang · Sichuan University

Xiong Lai · Sichuan University

Qing Mao · Sichuan University

Yanhui Liu · Beijing Hospital

Xiaoguang Qiu · Beijing Tian Tan Hospital

Abstract

In conclusion, high CDC6 expression may serve as a promising biomarker for prognosis and correlated with immune infiltrates, presenting to be a potential immune therapy target in glioma.

Topics & Keywords

Glioma Diagnosis and Treatment Immune cells in cancer Neuroinflammation and Neurodegeneration Mechanisms

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Molecular Cancer

Volume 21, Issue 1, pp. 153-153

DOI: 10.1186/s12943-022-01623-8

Field-Weighted Citation Impact: 6.58